Bosutinib Sandoz

Bosutinibum — cpr pell 500 mg

Sandoz Pharmaceuticals AG

Swissmedic69145
Dossier21900
Statut
Générique
OriginalBosulif
Remboursement
QP 10%
Modifications (2)